Home/Filings/4/0001209191-22-019202
4//SEC Filing

Zinda Michael 4

Accession 0001209191-22-019202

CIK 0001808158other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 4:04 PM ET

Size

4.8 KB

Accession

0001209191-22-019202

Insider Transaction Report

Form 4
Period: 2022-03-15
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
  • Sale

    Common Shares

    2022-03-15$11.30/sh533$6,02346,041 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

Issuer

Repare Therapeutics Inc.

CIK 0001808158

Entity typeother

Related Parties

1
  • filerCIK 0001815366

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:04 PM ET
Size
4.8 KB